Abstracts Archive - Page 362 of 1683 - ATC Abstracts

2020 American Transplant Congress
Transplantation from Donors with Positive Blood Culture
H. Mo, S. Min, H. Ko, C. Chung, H. Kim, A. Han, J. Ha
Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: The use of organs from donors with infection is limited because of the possibility of transmission. Herein we report our experience of transplantation from…
2020 American Transplant Congress
Impact of Organ Donor Infections on Kidney Transplant Recipient Outcomes
M. Santarossa¹, C. Muran², S. Sanchez², L. Heinrich², J. Yoo³, F. Albarillo¹, S. Akkina³, N. Clark¹, G. Reid¹
¹Department of Medicine, Division of Infectious Diseases, Loyola University Medical Center, Maywood, IL, ²Department of Pharmacy, Loyola University Medical Center, Maywood, IL, ³Department of Medicine, Division of Transplant Nephrology, Loyola University Medical Center, Maywood, IL
*Purpose: Donor-derived infections can lead to significant morbidity and mortality in organ transplant recipients. There is variability by center on treatment of positive donor cultures…
2020 American Transplant Congress
Cytomegalovirus Preemptive Monitoring Conversion and the Use of a Preemptive Threshold after Solid Organ Transplant
C. Wong, M. Jorgenson, J. Descourouez, C. Saddler, J. Smith, D. Mandelbrot
UWHC, Madison, WI
*Purpose: Cytomegalovirus (CMV) in solid organ transplant (SOT) is associated with negative graft and patient outcomes. Prophylactic agents of choice have substantial cytotoxicity, and patients…
2020 American Transplant Congress
Viral Kinetics of De Novo HCV Infection and Response to Antiviral Therapy in Liver and Kidney Transplant Recipients Receiving HCV-Viremic Donors
N. Terrault¹, J. Burton², E. Verna³, C. Mobley⁴, D. Victor⁴, J. Trotter⁵, C. Niemann⁶, R. Rubin⁷
¹University of Southern California, Los Angeles, CA, ²UC, Denver, CO, ³Columbia Universeity, New York, NY, ⁴Houston Methodist, Houston, TX, ⁵Baylor University, Dallas, TX, ⁶UCSF, San Francisco, CA, ⁷Piedmont Atlanta Hosptial, Atlanta, GA
*Purpose: There is general agreement that expanded use of organs from HCV-viremic donors is desirable, including in recipients without HCV infection. However, the optimal treatment…
2020 American Transplant Congress
Outcome after Kidney Transplantation in Hepatitis Surface Antigen-Positive Patients
H. Mo, S. Min, H. Ko, C. Chung, H. Kim, A. Han, J. Ha
Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Because of the low prevalence of Hepatitis Surface Antigen (HBsAg)-positive patients, only a few reports have evaluated the actual outcome of these patients after…
2020 American Transplant Congress
Evaluation of Cytomegalovirus Prophylaxis in Low and Intermediate Risk Kidney Transplant Recipients Receiving Lymphocyte-Depleting Induction
H. Stamps, K. Linder, D. O'Sullivan, F. Cheema, H. Kutzler
Hartford Hospital, Hartford, CT
*Purpose: This study evaluates if choice and duration of Cytomegalovirus (CMV) prophylaxis based on donor (D) and recipient (R) CMV serostatus impacts the incidence of…
2020 American Transplant Congress
Incidence of Cytomegalovirus Infection in Deceased Donor Kidney Transplantation from Hepatitis-C Antibody Positive Donors to Hepatitis-C Antibody Negative Recipients: A National Registry Analysis
M. Yazawa¹, T. Fülöp², O. Cseprekal³, M. Talwar¹, V. Balaraman¹, A. Bhalla¹, A. Azhar¹, C. P. Kovesdy⁴, J. D. Eason¹, M. Z. Molnar¹
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Division of Nephrology, Department of Medicine, Medical University of South Carolina, South Carolina, SC, ³Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, ⁴Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN
*Purpose: Deceased donor kidney transplantation (KT) from hepatitis C (HCV) infected donors into HCV uninfected recipients (HCV D+/R-) will be the standard of care in…
2020 American Transplant Congress
The Importance of Caveolin-1 Immunohistochemical Staining for BK Nephropathy Seen after Kidney Transplantation
E. Arpali¹, E. Sunnetcioglu², Y. Özlük², A. Turkmen³, F. S. Oğuz¹
¹Medical Biology, Istanbul University School of Medicine, Istanbul, Turkey, ²Pathology, Istanbul University School of Medicine, Istanbul, Turkey, ³Nephrology, Istanbul University School of Medicine, Istanbul, Turkey
*Purpose: To understand the importance of molecular expression of Caveolin-1 in BKV nephropathy seen after kidney transplantion.*Methods: The kidney transplant patients who had a graft…
2020 American Transplant Congress
Incidence and Outcomes of Secondary Cutaneous Malignancies among Renal Transplant Recipients
T. Maw¹, P. Vaidya¹, J. Samaan², S. Ghanshani¹, G. In¹
¹Keck School of Medicine, LA, CA, ²Cedar Sinai Hospital, LA, CA
*Purpose: Solid-organ transplant recipients on immunosuppressive therapy are known to have higher morbidity and mortality from secondary malignancies; however, there are no established guidelines for…
2020 American Transplant Congress
Immune Checkpoint Inhibitor Use in Kidney Transplant Recipients: Rejection Risk, Prevention and Transcriptional Signature in Allograft
N. Murakami¹, G. Reid², A. Weins¹, B. Adam², M. Mengel², L. Riella¹
¹Brigham and Women's Hospital, Boston, MA, ²University of Alberta, Edmonton, AB, Canada
*Purpose: Immune checkpoint inhibitor (ICI) use has changed the landscape of cancer treatment. Several cases of acute rejection in use of ICI have been reported,…